XR-17 is Oasmia’s proprietary delivery platform

CEO corner

Get to learn more about Francois Martelet, our CEO

Oasmia Pharmaceutical published its interim report for the second quarter of 2020 on December 9, 2020, at 08.00 am CET.

The Share

Oasmia and Elevar sign a global strategic partnership for the commercialization of Apealea®

Annual Report 2019 / 2020